Efficacy and Safety of TJ0113 Capsule in Patients With Parkinson's Disease

NCT06596005 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

149

Enrollment

OTHER

Sponsor class

Conditions

Parkinson Disease

Interventions

DRUG: TJ0113 200mg
DRUG: TJ0113 400mg
DRUG: Placebo

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]